Functional characterization of the RAD51D E233G genetic variant

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• RAD51D is crucial for DNA repair and telomere maintenance.
• A RAD51D variant, E233G, was identified as a potential susceptibility allele for familial breast cancer.
• The functional impact of this specific amino acid substitution on RAD51D was previously uncharacterized.

Purpose of the Study:

• To investigate the functional consequences of the RAD51D E233G variant.
• To determine the effects of the E233G substitution on protein interactions and cellular response to DNA damage.
• To explore the potential role of this variant in cancer therapy.

Main Methods:

• Complementation analysis using Rad51d-deficient mouse embryonic fibroblasts.
• Assays to measure cellular resistance to various DNA-damaging agents and taxol.
• Yeast two-hybrid analysis to assess protein-protein interactions.
• Molecular modeling to predict structural changes.

Main Results:

• The E233G variant increased cellular resistance to mitomycin C, cisplatin, MMS, UV light, and taxol.
• The variant reduced the anaphase bridge index, indicating improved telomere function.
• Interaction between RAD51C and RAD51D (E233G) was reduced, while XRCC2 interaction remained normal.
• Molecular modeling suggested disruption of interdomain interactions due to the E233G substitution.

Conclusions:

• The RAD51D E233G variant enhances chemoresistance and affects protein interactions and telomere function.
• This is the first study to functionally characterize a clinically relevant RAD51D amino acid substitution.
• Further research on this variant could yield insights into RAD51D's role in cancer treatment.